The global Hospital Injectable Drugs market size was valued at USD 41580 million in 2022 and is forecast to a readjusted size of USD 56940 million by 2029 with a CAGR of 4.6% during review period.
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bioequivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
In 2019, North America held the main share in global hospital injectable drugs market, with the proportion of 35%, Europe followed loosely, at the proportion of 33%. Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share (13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
This report is a detailed and comprehensive analysis for global Hospital Injectable Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hospital Injectable Drugs market size and forecasts, in consumption value ($ Million), 2018-2029
Global Hospital Injectable Drugs market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Hospital Injectable Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Hospital Injectable Drugs market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hospital Injectable Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hospital Injectable Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths
- Growing demand for injectable drugs due to the increasing prevalence of chronic diseases and the need for effective treatment options.
- Advancements in drug formulation and delivery technologies, enhancing the efficacy and safety of injectable medications.
Weaknesses
- High costs associated with research, development, and manufacturing of injectable drugs, impacting affordability for healthcare systems.
- Limited access to injectable drug therapies in rural and underserved areas, hindering market penetration.
Opportunities
- Expansion of biosimilars and generic injectable drugs, increasing market competition and driving down prices.
- Increasing adoption of self-administration devices, empowering patients and improving adherence to treatment regimens.
Threats
- Stringent regulatory requirements and prolonged approval processes for new injectable drugs, delaying market entry.
- Growing concerns over drug safety and efficacy, leading to potential product recalls and loss of consumer trust.
Political
- Government regulations and policies on healthcare spending may impact the affordability and accessibility of injectable drugs.
- Increasing government support for the development of biosimilars and generics, influencing market dynamics.
Economic
- Rising healthcare costs and pressures on hospital budgets may limit the adoption of expensive injectable drugs.
- Economic growth in emerging markets offers new opportunities for market expansion and increased demand for injectable therapies.
Social
- The growing aging population and rising prevalence of chronic conditions will drive demand for injectable drug therapies.
- Increasing patient preference for self-injection and home care solutions enhances the adoption of injectable drugs.
Technological
- Advancements in drug delivery systems, including prefilled syringes and auto-injectors, are enhancing the convenience and effectiveness of injectable therapies.
- Innovations in biotechnology, such as the development of personalized injectables, are shaping the future of the market.
Environmental
- Growing emphasis on sustainable practices in the pharmaceutical industry, including eco-friendly packaging and waste reduction.
- Environmental regulations affecting the production and disposal of injectable drug packaging may increase operational costs.
Legal
- Stringent regulatory frameworks for injectable drug approval and monitoring, influencing market entry timelines.
- Increasing intellectual property concerns and patent expirations leading to a rise in generic injectable drug competition.
Suppliers
- Pharmaceutical manufacturers and biotechnology companies producing innovative injectable drugs and biosimilars.
- Raw material suppliers for the production of syringes, vials, and other injectable drug components.
Inputs
- Active pharmaceutical ingredients (APIs) and excipients for drug formulation.
- Research and development data for drug efficacy and safety testing.
Process
- Manufacturing and packaging of injectable drugs, ensuring compliance with regulatory standards.
- Distribution to hospitals, clinics, and healthcare providers for patient administration.
Outputs
- Finished injectable drug products, including prefilled syringes, vials, and auto-injectors.
- Market reports and sales data to assess demand and distribution trends in different regions.
Customers
- Hospitals and healthcare providers administering injectable drugs for patient treatment.
- Patients requiring injectable drug therapies, including those with chronic diseases or in need of emergency care.
Threat of New Entrants
- High capital investment and regulatory hurdles for new companies entering the injectable drug market limit new competition.
- Established brand loyalty and strong market presence of leading pharmaceutical companies create significant barriers to entry.
Bargaining Power of Suppliers
- Limited number of suppliers for specialized raw materials and active pharmaceutical ingredients (APIs) increases supplier power.
- Dependency on high-quality manufacturing equipment and technology further strengthens supplier influence in the market.
Bargaining Power of Buyers
- Hospitals and healthcare providers hold significant bargaining power due to their volume purchasing capabilities and demand for cost-effective therapies.
- The growing availability of generics and biosimilars increases buyer power by providing more treatment options at lower prices.
Threat of Substitutes
- The availability of oral medications and non-injectable therapies for certain diseases poses a moderate threat to injectable drug demand.
- Technological advancements in oral drug delivery systems may offer viable alternatives to injectable treatments in the future.
Industry Rivalry
- Intense competition between established pharmaceutical companies, especially in the biosimilars and generics segments, drives innovation and price competition.
- Differentiation in drug efficacy, delivery systems, and packaging creates a competitive environment among manufacturers.
Raw Materials and Components
- The availability and cost of high-quality active pharmaceutical ingredients (APIs) are critical to the production of injectable drugs.
- The sourcing of packaging materials such as prefilled syringes, vials, and stoppers impacts the overall production cost and supply chain efficiency.
Technology and Manufacturing
- Advanced manufacturing technologies, including aseptic processing and high-precision filling systems, are essential to meet quality and regulatory standards.
- Automation and digitalization in the production process can improve efficiency, reduce errors, and lower production costs for injectable drugs.
Regulatory Environment
- Compliance with stringent regulatory requirements for drug development, manufacturing, and approval is a significant factor in the upstream process.
- Evolving regulatory guidelines, such as those for biosimilars, can impact the development timelines and costs of injectable drug products.
Suppliers and Partnerships
- Collaboration with biotechnology firms and contract manufacturing organizations (CMOs) enhances the ability to innovate and scale production.
- Supplier reliability and long-term partnerships are critical to ensure consistent quality and supply of raw materials and components.
Production and Manufacturing
- Streamlining production processes through automation and technology integration ensures compliance with regulatory standards and reduces operational costs.
- Quality control measures during manufacturing, including sterile conditions and batch testing, are essential to ensure the safety and efficacy of injectable drugs.
Distribution and Logistics
- Efficient distribution networks and cold chain logistics are critical to maintain the integrity and stability of injectable drugs during transportation.
- Increasing demand for injectable drugs in emerging markets requires the expansion of distribution infrastructure to ensure timely and reliable delivery.
Regulatory and Compliance
- Adherence to global regulatory requirements, such as those set by the FDA and EMA, is crucial to market access and avoiding product recalls.
- Constant updates and changes in regulations may require midstream players to adapt quickly, impacting production schedules and distribution strategies.
Market Access and Pricing
- Strategic partnerships with hospitals and healthcare providers help in negotiating favorable pricing and ensuring market access for injectable drug products.
- The cost-effectiveness of injectable drugs plays a significant role in securing market share, especially in competitive segments such as generics and biosimilars.
Healthcare Providers and Hospitals
- Hospitals and healthcare providers will play a critical role in the adoption and administration of injectable drugs, influencing their market demand.
- Integration of advanced injectable drug therapies into hospital formularies and treatment protocols enhances patient outcomes and drives drug usage.
Patients and End-Users
- Increasing patient awareness of injectable treatments, particularly for chronic conditions, is expected to boost demand for hospital injectable drugs.
- The growing trend of home healthcare and self-injection devices allows patients greater control, potentially increasing patient adherence and drug utilization.
Market Competition and Pricing
- Competition from biosimilars and generics is expected to drive down prices, making injectable drugs more affordable for healthcare systems and patients.
- The differentiation of injectable drug products through unique delivery systems or formulations can help brands capture greater market share.
Regulatory and Legal Factors
- Post-market surveillance and continued regulatory scrutiny will influence the adoption and longevity of injectable drugs in the market.
- Patent expirations and intellectual property issues will lead to increased competition from generic injectable drugs, potentially affecting pricing strategies.
Chapter 1, to describe Hospital Injectable Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital Injectable Drugs, with revenue, gross margin and global market share of Hospital Injectable Drugs from 2018 to 2023.
Chapter 3, the Hospital Injectable Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hospital Injectable Drugs market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital Injectable Drugs.
Chapter 13, to describe Hospital Injectable Drugs research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Hospital Injectable Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital Injectable Drugs by Type
1.3.1 Overview: Global Hospital Injectable Drugs Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Hospital Injectable Drugs Consumption Value Market Share by Type in 2022
1.3.3 Generic Sterile Injectables
1.3.4 Sterile Intravenous (IV) Solutions
1.4 Global Hospital Injectable Drugs Market by Application
1.4.1 Overview: Global Hospital Injectable Drugs Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Oncology
1.4.3 Anesthesia
1.4.4 Anti-Infectives
1.4.5 Parenteral Nutrition
1.4.6 Cardiovascular Diseases
1.5 Global Hospital Injectable Drugs Market Size & Forecast
1.6 Global Hospital Injectable Drugs Market Size and Forecast by Region
1.6.1 Global Hospital Injectable Drugs Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Hospital Injectable Drugs Market Size by Region, (2018-2029)
1.6.3 North America Hospital Injectable Drugs Market Size and Prospect (2018-2029)
1.6.4 Europe Hospital Injectable Drugs Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Hospital Injectable Drugs Market Size and Prospect (2018-2029)
1.6.6 South America Hospital Injectable Drugs Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Hospital Injectable Drugs Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Hospira (Pfizer Inc.)
2.1.1 Hospira (Pfizer Inc.) Details
2.1.2 Hospira (Pfizer Inc.) Major Business
2.1.3 Hospira (Pfizer Inc.) Hospital Injectable Drugs Product and Solutions
2.1.4 Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hospira (Pfizer Inc.) Recent Developments and Future Plans
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Hospital Injectable Drugs Product and Solutions
2.2.4 Baxter Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Baxter Recent Developments and Future Plans
2.3 Fresenius Kabi
2.3.1 Fresenius Kabi Details
2.3.2 Fresenius Kabi Major Business
2.3.3 Fresenius Kabi Hospital Injectable Drugs Product and Solutions
2.3.4 Fresenius Kabi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Fresenius Kabi Recent Developments and Future Plans
2.4 Sandoz (Novartis)
2.4.1 Sandoz (Novartis) Details
2.4.2 Sandoz (Novartis) Major Business
2.4.3 Sandoz (Novartis) Hospital Injectable Drugs Product and Solutions
2.4.4 Sandoz (Novartis) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sandoz (Novartis) Recent Developments and Future Plans
2.5 Hikma Pharmaceuticals PLC
2.5.1 Hikma Pharmaceuticals PLC Details
2.5.2 Hikma Pharmaceuticals PLC Major Business
2.5.3 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product and Solutions
2.5.4 Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hikma Pharmaceuticals PLC Recent Developments and Future Plans
2.6 Dr. Reddy’s Laboratories Ltd
2.6.1 Dr. Reddy’s Laboratories Ltd Details
2.6.2 Dr. Reddy’s Laboratories Ltd Major Business
2.6.3 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product and Solutions
2.6.4 Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
2.7 Grifols
2.7.1 Grifols Details
2.7.2 Grifols Major Business
2.7.3 Grifols Hospital Injectable Drugs Product and Solutions
2.7.4 Grifols Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Grifols Recent Developments and Future Plans
2.8 Nichi-Iko Group (Sagent)
2.8.1 Nichi-Iko Group (Sagent) Details
2.8.2 Nichi-Iko Group (Sagent) Major Business
2.8.3 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product and Solutions
2.8.4 Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nichi-Iko Group (Sagent) Recent Developments and Future Plans
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.9.4 Teva Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Teva Pharmaceutical Recent Developments and Future Plans
2.10 Otsuka
2.10.1 Otsuka Details
2.10.2 Otsuka Major Business
2.10.3 Otsuka Hospital Injectable Drugs Product and Solutions
2.10.4 Otsuka Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Otsuka Recent Developments and Future Plans
2.11 B.Braun
2.11.1 B.Braun Details
2.11.2 B.Braun Major Business
2.11.3 B.Braun Hospital Injectable Drugs Product and Solutions
2.11.4 B.Braun Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 B.Braun Recent Developments and Future Plans
2.12 JW Life Science
2.12.1 JW Life Science Details
2.12.2 JW Life Science Major Business
2.12.3 JW Life Science Hospital Injectable Drugs Product and Solutions
2.12.4 JW Life Science Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 JW Life Science Recent Developments and Future Plans
2.13 Auromedics
2.13.1 Auromedics Details
2.13.2 Auromedics Major Business
2.13.3 Auromedics Hospital Injectable Drugs Product and Solutions
2.13.4 Auromedics Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Auromedics Recent Developments and Future Plans
2.14 Sanofi
2.14.1 Sanofi Details
2.14.2 Sanofi Major Business
2.14.3 Sanofi Hospital Injectable Drugs Product and Solutions
2.14.4 Sanofi Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Sanofi Recent Developments and Future Plans
2.15 Gland Pharma
2.15.1 Gland Pharma Details
2.15.2 Gland Pharma Major Business
2.15.3 Gland Pharma Hospital Injectable Drugs Product and Solutions
2.15.4 Gland Pharma Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Gland Pharma Recent Developments and Future Plans
2.16 Endo International PLC
2.16.1 Endo International PLC Details
2.16.2 Endo International PLC Major Business
2.16.3 Endo International PLC Hospital Injectable Drugs Product and Solutions
2.16.4 Endo International PLC Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Endo International PLC Recent Developments and Future Plans
2.17 Sichuan Kelun Pharmaceutical
2.17.1 Sichuan Kelun Pharmaceutical Details
2.17.2 Sichuan Kelun Pharmaceutical Major Business
2.17.3 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.17.4 Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
2.18 Cisen Pharmaceutical
2.18.1 Cisen Pharmaceutical Details
2.18.2 Cisen Pharmaceutical Major Business
2.18.3 Cisen Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.18.4 Cisen Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Cisen Pharmaceutical Recent Developments and Future Plans
2.19 Shijiazhuang No. 4 Pharmaceutical
2.19.1 Shijiazhuang No. 4 Pharmaceutical Details
2.19.2 Shijiazhuang No. 4 Pharmaceutical Major Business
2.19.3 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.19.4 Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Shijiazhuang No. 4 Pharmaceutical Recent Developments and Future Plans
2.20 Shandong Hualu Pharmaceutical
2.20.1 Shandong Hualu Pharmaceutical Details
2.20.2 Shandong Hualu Pharmaceutical Major Business
2.20.3 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product and Solutions
2.20.4 Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Shandong Hualu Pharmaceutical Recent Developments and Future Plans
2.21 CR Double-Crane
2.21.1 CR Double-Crane Details
2.21.2 CR Double-Crane Major Business
2.21.3 CR Double-Crane Hospital Injectable Drugs Product and Solutions
2.21.4 CR Double-Crane Hospital Injectable Drugs Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 CR Double-Crane Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hospital Injectable Drugs Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Hospital Injectable Drugs by Company Revenue
3.2.2 Top 3 Hospital Injectable Drugs Players Market Share in 2022
3.2.3 Top 6 Hospital Injectable Drugs Players Market Share in 2022
3.3 Hospital Injectable Drugs Market: Overall Company Footprint Analysis
3.3.1 Hospital Injectable Drugs Market: Region Footprint
3.3.2 Hospital Injectable Drugs Market: Company Product Type Footprint
3.3.3 Hospital Injectable Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Hospital Injectable Drugs Consumption Value and Market Share by Type (2018-2023)
4.2 Global Hospital Injectable Drugs Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Hospital Injectable Drugs Consumption Value Market Share by Application (2018-2023)
5.2 Global Hospital Injectable Drugs Market Forecast by Application (2024-2029)
6 North America
6.1 North America Hospital Injectable Drugs Consumption Value by Type (2018-2029)
6.2 North America Hospital Injectable Drugs Consumption Value by Application (2018-2029)
6.3 North America Hospital Injectable Drugs Market Size by Country
6.3.1 North America Hospital Injectable Drugs Consumption Value by Country (2018-2029)
6.3.2 United States Hospital Injectable Drugs Market Size and Forecast (2018-2029)
6.3.3 Canada Hospital Injectable Drugs Market Size and Forecast (2018-2029)
6.3.4 Mexico Hospital Injectable Drugs Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Hospital Injectable Drugs Consumption Value by Type (2018-2029)
7.2 Europe Hospital Injectable Drugs Consumption Value by Application (2018-2029)
7.3 Europe Hospital Injectable Drugs Market Size by Country
7.3.1 Europe Hospital Injectable Drugs Consumption Value by Country (2018-2029)
7.3.2 Germany Hospital Injectable Drugs Market Size and Forecast (2018-2029)
7.3.3 France Hospital Injectable Drugs Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Hospital Injectable Drugs Market Size and Forecast (2018-2029)
7.3.5 Russia Hospital Injectable Drugs Market Size and Forecast (2018-2029)
7.3.6 Italy Hospital Injectable Drugs Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Hospital Injectable Drugs Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Hospital Injectable Drugs Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Hospital Injectable Drugs Market Size by Region
8.3.1 Asia-Pacific Hospital Injectable Drugs Consumption Value by Region (2018-2029)
8.3.2 China Hospital Injectable Drugs Market Size and Forecast (2018-2029)
8.3.3 Japan Hospital Injectable Drugs Market Size and Forecast (2018-2029)
8.3.4 South Korea Hospital Injectable Drugs Market Size and Forecast (2018-2029)
8.3.5 India Hospital Injectable Drugs Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Hospital Injectable Drugs Market Size and Forecast (2018-2029)
8.3.7 Australia Hospital Injectable Drugs Market Size and Forecast (2018-2029)
9 South America
9.1 South America Hospital Injectable Drugs Consumption Value by Type (2018-2029)
9.2 South America Hospital Injectable Drugs Consumption Value by Application (2018-2029)
9.3 South America Hospital Injectable Drugs Market Size by Country
9.3.1 South America Hospital Injectable Drugs Consumption Value by Country (2018-2029)
9.3.2 Brazil Hospital Injectable Drugs Market Size and Forecast (2018-2029)
9.3.3 Argentina Hospital Injectable Drugs Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Hospital Injectable Drugs Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Hospital Injectable Drugs Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Hospital Injectable Drugs Market Size by Country
10.3.1 Middle East & Africa Hospital Injectable Drugs Consumption Value by Country (2018-2029)
10.3.2 Turkey Hospital Injectable Drugs Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Hospital Injectable Drugs Market Size and Forecast (2018-2029)
10.3.4 UAE Hospital Injectable Drugs Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Hospital Injectable Drugs Market Drivers
11.2 Hospital Injectable Drugs Market Restraints
11.3 Hospital Injectable Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Hospital Injectable Drugs Industry Chain
12.2 Hospital Injectable Drugs Upstream Analysis
12.3 Hospital Injectable Drugs Midstream Analysis
12.4 Hospital Injectable Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Hospital Injectable Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hospital Injectable Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Hospital Injectable Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Hospital Injectable Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Hospira (Pfizer Inc.) Company Information, Head Office, and Major Competitors
Table 6. Hospira (Pfizer Inc.) Major Business
Table 7. Hospira (Pfizer Inc.) Hospital Injectable Drugs Product and Solutions
Table 8. Hospira (Pfizer Inc.) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Hospira (Pfizer Inc.) Recent Developments and Future Plans
Table 10. Baxter Company Information, Head Office, and Major Competitors
Table 11. Baxter Major Business
Table 12. Baxter Hospital Injectable Drugs Product and Solutions
Table 13. Baxter Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Baxter Recent Developments and Future Plans
Table 15. Fresenius Kabi Company Information, Head Office, and Major Competitors
Table 16. Fresenius Kabi Major Business
Table 17. Fresenius Kabi Hospital Injectable Drugs Product and Solutions
Table 18. Fresenius Kabi Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Fresenius Kabi Recent Developments and Future Plans
Table 20. Sandoz (Novartis) Company Information, Head Office, and Major Competitors
Table 21. Sandoz (Novartis) Major Business
Table 22. Sandoz (Novartis) Hospital Injectable Drugs Product and Solutions
Table 23. Sandoz (Novartis) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sandoz (Novartis) Recent Developments and Future Plans
Table 25. Hikma Pharmaceuticals PLC Company Information, Head Office, and Major Competitors
Table 26. Hikma Pharmaceuticals PLC Major Business
Table 27. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Product and Solutions
Table 28. Hikma Pharmaceuticals PLC Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hikma Pharmaceuticals PLC Recent Developments and Future Plans
Table 30. Dr. Reddy’s Laboratories Ltd Company Information, Head Office, and Major Competitors
Table 31. Dr. Reddy’s Laboratories Ltd Major Business
Table 32. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Product and Solutions
Table 33. Dr. Reddy’s Laboratories Ltd Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
Table 35. Grifols Company Information, Head Office, and Major Competitors
Table 36. Grifols Major Business
Table 37. Grifols Hospital Injectable Drugs Product and Solutions
Table 38. Grifols Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Grifols Recent Developments and Future Plans
Table 40. Nichi-Iko Group (Sagent) Company Information, Head Office, and Major Competitors
Table 41. Nichi-Iko Group (Sagent) Major Business
Table 42. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Product and Solutions
Table 43. Nichi-Iko Group (Sagent) Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Nichi-Iko Group (Sagent) Recent Developments and Future Plans
Table 45. Teva Pharmaceutical Company Information, Head Office, and Major Competitors
Table 46. Teva Pharmaceutical Major Business
Table 47. Teva Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 48. Teva Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Teva Pharmaceutical Recent Developments and Future Plans
Table 50. Otsuka Company Information, Head Office, and Major Competitors
Table 51. Otsuka Major Business
Table 52. Otsuka Hospital Injectable Drugs Product and Solutions
Table 53. Otsuka Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Otsuka Recent Developments and Future Plans
Table 55. B.Braun Company Information, Head Office, and Major Competitors
Table 56. B.Braun Major Business
Table 57. B.Braun Hospital Injectable Drugs Product and Solutions
Table 58. B.Braun Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. B.Braun Recent Developments and Future Plans
Table 60. JW Life Science Company Information, Head Office, and Major Competitors
Table 61. JW Life Science Major Business
Table 62. JW Life Science Hospital Injectable Drugs Product and Solutions
Table 63. JW Life Science Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. JW Life Science Recent Developments and Future Plans
Table 65. Auromedics Company Information, Head Office, and Major Competitors
Table 66. Auromedics Major Business
Table 67. Auromedics Hospital Injectable Drugs Product and Solutions
Table 68. Auromedics Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Auromedics Recent Developments and Future Plans
Table 70. Sanofi Company Information, Head Office, and Major Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Hospital Injectable Drugs Product and Solutions
Table 73. Sanofi Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Sanofi Recent Developments and Future Plans
Table 75. Gland Pharma Company Information, Head Office, and Major Competitors
Table 76. Gland Pharma Major Business
Table 77. Gland Pharma Hospital Injectable Drugs Product and Solutions
Table 78. Gland Pharma Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Gland Pharma Recent Developments and Future Plans
Table 80. Endo International PLC Company Information, Head Office, and Major Competitors
Table 81. Endo International PLC Major Business
Table 82. Endo International PLC Hospital Injectable Drugs Product and Solutions
Table 83. Endo International PLC Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Endo International PLC Recent Developments and Future Plans
Table 85. Sichuan Kelun Pharmaceutical Company Information, Head Office, and Major Competitors
Table 86. Sichuan Kelun Pharmaceutical Major Business
Table 87. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 88. Sichuan Kelun Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sichuan Kelun Pharmaceutical Recent Developments and Future Plans
Table 90. Cisen Pharmaceutical Company Information, Head Office, and Major Competitors
Table 91. Cisen Pharmaceutical Major Business
Table 92. Cisen Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 93. Cisen Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Cisen Pharmaceutical Recent Developments and Future Plans
Table 95. Shijiazhuang No. 4 Pharmaceutical Company Information, Head Office, and Major Competitors
Table 96. Shijiazhuang No. 4 Pharmaceutical Major Business
Table 97. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 98. Shijiazhuang No. 4 Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Shijiazhuang No. 4 Pharmaceutical Recent Developments and Future Plans
Table 100. Shandong Hualu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 101. Shandong Hualu Pharmaceutical Major Business
Table 102. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Product and Solutions
Table 103. Shandong Hualu Pharmaceutical Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Shandong Hualu Pharmaceutical Recent Developments and Future Plans
Table 105. CR Double-Crane Company Information, Head Office, and Major Competitors
Table 106. CR Double-Crane Major Business
Table 107. CR Double-Crane Hospital Injectable Drugs Product and Solutions
Table 108. CR Double-Crane Hospital Injectable Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. CR Double-Crane Recent Developments and Future Plans
Table 110. Global Hospital Injectable Drugs Revenue (USD Million) by Players (2018-2023)
Table 111. Global Hospital Injectable Drugs Revenue Share by Players (2018-2023)
Table 112. Breakdown of Hospital Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 113. Market Position of Players in Hospital Injectable Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 114. Head Office of Key Hospital Injectable Drugs Players
Table 115. Hospital Injectable Drugs Market: Company Product Type Footprint
Table 116. Hospital Injectable Drugs Market: Company Product Application Footprint
Table 117. Hospital Injectable Drugs New Market Entrants and Barriers to Market Entry
Table 118. Hospital Injectable Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 119. Global Hospital Injectable Drugs Consumption Value (USD Million) by Type (2018-2023)
Table 120. Global Hospital Injectable Drugs Consumption Value Share by Type (2018-2023)
Table 121. Global Hospital Injectable Drugs Consumption Value Forecast by Type (2024-2029)
Table 122. Global Hospital Injectable Drugs Consumption Value by Application (2018-2023)
Table 123. Global Hospital Injectable Drugs Consumption Value Forecast by Application (2024-2029)
Table 124. North America Hospital Injectable Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 125. North America Hospital Injectable Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 126. North America Hospital Injectable Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 127. North America Hospital Injectable Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 128. North America Hospital Injectable Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 129. North America Hospital Injectable Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 130. Europe Hospital Injectable Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 131. Europe Hospital Injectable Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 132. Europe Hospital Injectable Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 133. Europe Hospital Injectable Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 134. Europe Hospital Injectable Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Hospital Injectable Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Hospital Injectable Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 137. Asia-Pacific Hospital Injectable Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 138. Asia-Pacific Hospital Injectable Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 139. Asia-Pacific Hospital Injectable Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 140. Asia-Pacific Hospital Injectable Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 141. Asia-Pacific Hospital Injectable Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 142. South America Hospital Injectable Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 143. South America Hospital Injectable Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 144. South America Hospital Injectable Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 145. South America Hospital Injectable Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 146. South America Hospital Injectable Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 147. South America Hospital Injectable Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 148. Middle East & Africa Hospital Injectable Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 149. Middle East & Africa Hospital Injectable Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 150. Middle East & Africa Hospital Injectable Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 151. Middle East & Africa Hospital Injectable Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 152. Middle East & Africa Hospital Injectable Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 153. Middle East & Africa Hospital Injectable Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 154. Hospital Injectable Drugs Raw Material
Table 155. Key Suppliers of Hospital Injectable Drugs Raw Materials
List of Figures
Figure 1. Hospital Injectable Drugs Picture
Figure 2. Global Hospital Injectable Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hospital Injectable Drugs Consumption Value Market Share by Type in 2022
Figure 4. Generic Sterile Injectables
Figure 5. Sterile Intravenous (IV) Solutions
Figure 6. Global Hospital Injectable Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Hospital Injectable Drugs Consumption Value Market Share by Application in 2022
Figure 8. Oncology Picture
Figure 9. Anesthesia Picture
Figure 10. Anti-Infectives Picture
Figure 11. Parenteral Nutrition Picture
Figure 12. Cardiovascular Diseases Picture
Figure 13. Global Hospital Injectable Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Hospital Injectable Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Hospital Injectable Drugs Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Hospital Injectable Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Hospital Injectable Drugs Consumption Value Market Share by Region in 2022
Figure 18. North America Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Hospital Injectable Drugs Revenue Share by Players in 2022
Figure 24. Hospital Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Hospital Injectable Drugs Market Share in 2022
Figure 26. Global Top 6 Players Hospital Injectable Drugs Market Share in 2022
Figure 27. Global Hospital Injectable Drugs Consumption Value Share by Type (2018-2023)
Figure 28. Global Hospital Injectable Drugs Market Share Forecast by Type (2024-2029)
Figure 29. Global Hospital Injectable Drugs Consumption Value Share by Application (2018-2023)
Figure 30. Global Hospital Injectable Drugs Market Share Forecast by Application (2024-2029)
Figure 31. North America Hospital Injectable Drugs Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Hospital Injectable Drugs Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Hospital Injectable Drugs Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Hospital Injectable Drugs Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Hospital Injectable Drugs Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Hospital Injectable Drugs Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 41. France Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Hospital Injectable Drugs Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Hospital Injectable Drugs Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Hospital Injectable Drugs Consumption Value Market Share by Region (2018-2029)
Figure 48. China Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 51. India Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Hospital Injectable Drugs Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Hospital Injectable Drugs Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Hospital Injectable Drugs Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Hospital Injectable Drugs Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Hospital Injectable Drugs Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Hospital Injectable Drugs Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Hospital Injectable Drugs Consumption Value (2018-2029) & (USD Million)
Figure 65. Hospital Injectable Drugs Market Drivers
Figure 66. Hospital Injectable Drugs Market Restraints
Figure 67. Hospital Injectable Drugs Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Hospital Injectable Drugs in 2022
Figure 70. Manufacturing Process Analysis of Hospital Injectable Drugs
Figure 71. Hospital Injectable Drugs Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
